New Story
Cipla share price gains 2% on Q4 numbers; files application for asthma drug with USFDA
May 17, 2020 | By Moneycontrol.com
business
The company announced the submission of an ANDA for Fluticasone propionate and Salmeterol inhalation powder with the US drug regulator.
:
The share price of Cipla gained 2 percent in the early trade on May 18 after the pharma company reported its Q4 numbers and filed an application for a new drug with the US drug regulator. The company declared a profit after tax of Rs 246 crore for the quarte
...
It’s time to compare and apply for the best loan offers at Afinoz. We are a leading online financial marketplace for Personal Loans, Business Loan,Education Loan,Home Loan & Car Loan and Investment Products. Our system intelligence and the automated system offers the best options to you for the real-time tracking of your loan application in an easy manner. Stay tuned to latest updates in the industry at Afinoz.com
blog
Shares in depository account can be used as margin...
May 25, 2020
blog
Lufthansa clinches $10 billion bailout from German...
May 25, 2020
blog
Startup Livspace lays off 450 employees on adverse...
May 25, 2020
blog
HomeCapital gets fresh funding from Varanium NexGe...
May 25, 2020
blog
India looks to store cheap oil in United States: O...
May 25, 2020
blog
India looks to store cheap oil in United States: D...
May 25, 2020
blog
Daimler forges ahead with its plans to make all
May 25, 2020
blog
Trade Setup for Tuesday: Top 15 things to know bef...
May 25, 2020
Check your Personal Loan Eligibility
To check how much loan you can get.
Loan Amount
Monthly Income?
EMI's
Email
Company Name
Mobile Number
Verify

Related News:-

Helpline Number
+91-11-23978046
Covid 19
Global
0
Covid 19
India
0